Nurse Practitioner, Family · Dracut, MA
NPI
1013451921
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9 Loon Hill Rd Ste 301
Dracut, MA, 01826
Phone (978) 323-0360
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
767 services
Medicare patients, 2024
162
Average age 70
Drug cost, 2024
$1.8M
3,417 prescriptions
Company payments, 2025
$555
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charmy Patel was code 99214 (office e&m - established), 302 times for 135 patients. In total Charmy Patel billed 767 services in 10 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 302 | 135 | $86.36 | $26K |
| 95251 Test - Miscellaneous | Office | 186 | 83 | $23.04 | $4,286 |
| 82962 Clinical Chemistry | Office | 82 | 60 | $3.21 | $263 |
| 99213 Office E&M - Established | Office | 77 | 59 | $55.58 | $4,280 |
| 83036 Blood Count | Office | 60 | 54 | $9.52 | $571 |
| 82947 Clinical Chemistry | Office | 29 | 29 | $3.72 | $108 |
| 99204 Office E&M - New | Office | 13 | 13 | $115.93 | $1,507 |
By year: 2022 $18K for 333 services; 2023 $37K for 924 services; 2024 $39K for 767 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 82 | 60 | $3.21 | $263 |
| 83036 Blood Count | 60 | 54 | $9.52 | $571 |
| 82947 Clinical Chemistry | 29 | 29 | $3.72 | $108 |
Medicare prescription drug claims, 2024
In 2024, the drug Charmy Patel prescribed most often to Medicare patients was Ozempic (Semaglutide), with 286 prescriptions and refills. In total Charmy Patel wrote 3,417 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 286 | 486 | 67 | $448K |
| Metformin Hcl Er Metformin Hcl | 221 | 535 | 70 | $3,117 |
| Metformin Hcl Generic | 217 | 494 | 66 | $2,129 |
| Mounjaro Tirzepatide | 167 | 204 | 37 | $215K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 159 | 423 | 78 | $16K |
| Jardiance Empagliflozin | 156 | 338 | 46 | $191K |
| Trulicity Dulaglutide | 123 | 158 | 36 | $151K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 117 | 282 | 38 | $108K |
| Humalog Mix 50-50 Kwikpen Insulin Lispro Protamin/Lispro | 104 | 185 | 32 | $38K |
| Atorvastatin Calcium Generic | 92 | 230 | 30 | $1,566 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 88 | 143 | 26 | $20K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 82 | 217 | 38 | $10K |
| Tresiba Flextouch U-200 Insulin Degludec | 79 | 197 | 34 | $90K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 69 | 193 | 31 | $6,654 |
| Gabapentin Generic | 65 | 131 | 18 | $892 |
Brand drugs: 1,824 claims; generic drugs: 1,088 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charmy Patel $555 ($555 in general payments such as food, travel and fees) from 12 companies. The largest payer was Dexcom, Inc. with $132.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 1 | $132 |
| Lilly USA, LLC LLY | 4 | $90.61 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $53.3 |
| Novo Nordisk Inc NVO | 2 | $45.14 |
| Medtronic, Inc. MDT | 2 | $41.42 |
| CeQur Corporation | 1 | $34.99 |
| Insulet Corporation PODD | 1 | $33.95 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $30.21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.79 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $26.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.